1. Review recent data on the efficacy of pre-exposure prophylaxis (PrEP), particularly in teens and younger adults
  2. Cite the results of two clinical trials of new antiretroviral agents
  3. Discuss recent findings with two drug ART regimens for ongoing viral suppression


Session date: 
11/13/2017 - 12:00pm to 1:00pm CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Resnlow Sherer, MD